Does low SHBG change the balance between total and free testosterone and complicate androgen status interpretation?

The relationship between Sex Hormone-Binding Globulin (SHBG) and testosterone is fundamental to assessing androgen status, particularly in middle-aged men where metabolic factors often influence protein levels. SHBG serves as the primary transport protein for testosterone, and its concentration dictates the distribution of the hormone between bound (inactive) and unbound (biologically active) states.

Mechanistic basis of binding

SHBG binds testosterone with high affinity in its amino-terminal laminin G-like domain. This interaction is structurally mediated by a hydrophobic pocket where testosterone forms specific hydrogen bonds and interactions with residues such as SER42, PHE67, MET107, and MET139.

• Binding Affinity: The dissociation constant ($K_d$) for testosterone is approximately 44 nM.
• Fractional Distribution: In a healthy male, roughly 45–60% of circulating testosterone is bound to SHBG, while approximately 40% is weakly bound to albumin. Only the remaining 2–3% exists as "free" testosterone.
• Equilibrium Shifts: Because SHBG has such a high affinity for testosterone, even minor fluctuations in SHBG levels significantly alter the equilibrium. When SHBG is low, the binding capacity of the blood is reduced, which mathematically increases the proportion of testosterone that remains in the free, biologically active form relative to the total pool.

Clinical evidence and diagnostic interpretation

Low SHBG concentrations—often secondary to obesity, hyperinsulinemia, or metabolic syndrome—frequently result in low measured total testosterone levels, even when the actual bioavailable androgen supply is adequate.

• Total vs. Free Testosterone: Because total testosterone assays measure both bound and unbound fractions, a reduction in SHBG inherently lowers the "Total T" value. This can lead to a "false-positive" biochemical diagnosis of hypogonadism if clinicians rely solely on total testosterone thresholds.
• Diagnostic Pitfalls: Research indicates that in cases of low SHBG, total testosterone is a poor indicator of androgen status. Clinical guidelines, including those from the Endocrine Society, recommend measuring or calculating free testosterone to accurately assess bioactivity.
• Calculation Limitations: While the Vermeulen formula is commonly used to calculate free testosterone, it may become less reliable or overestimate the free fraction when SHBG levels are pathologically low (e.g., <14 nmol/L).

Clinical implications

For a 53-year-old male, interpreting androgen status requires a nuanced approach that accounts for the SHBG-testosterone balance.

• Symptom Correlation: Accurate interpretation must correlate biochemical data with clinical symptoms such as fatigue or low libido, as the "normal" range for total testosterone may not apply when SHBG is suppressed.
• Gold Standard Testing: In complex cases where calculated values are suspect, equilibrium dialysis (ED) remains the gold standard for directly measuring the free testosterone fraction, bypassing the confounding effects of SHBG variability.

Bottom line

Low SHBG levels artificially depress total testosterone concentrations while increasing the ratio of free-to-total testosterone. To avoid misdiagnosis, androgen status should be interpreted using free testosterone measurements and clinical symptoms rather than total testosterone alone.